Greensboro, NC, United States of America

Muralidhar Bondlela

USPTO Granted Patents = 10 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 202(Granted Patents)

Location History:

High Point, NC (US) (2008)
Greensboro, NC (US) (2009 - 2015)

Company Filing History:

7 out of 49

Transtech Pharma, Inc.

High Point Pharmaceuticals, LLC

patents

Years Active: 2008-2015

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9175003 - Substituted azoanthracene derivatives and intermediates for preparation thereof (2015-11-03),

2. 9162963 - Phenylglyoxylic acid derivatives and their preparation and use (2015-10-20),

3. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof (2015-06-02),

4. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),

5. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof (2014-06-03),

6. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof (2013-04-30),

7. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),

8. 7582673 - Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use (2009-09-01),

9. 7501538 - Aryl and heteroaryl compounds, compositions and methods of use (2009-03-10),

10. 7459472 - Aryl and heteroaryl compounds, compositions, and methods of use (2008-12-02),

Title: Muralidhar Bondlela: Pioneering Innovator in Pharmaceuticals

Introduction:

Muralidhar Bondlela, a brilliant inventor based in Greensboro, NC, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 10 patents, his work revolves around developing novel compounds for the treatment and prevention of various diseases.

Latest Patents:

Bondlela's recent patents showcase his expertise in creating cutting-edge pharmaceutical compositions. One of his latest inventions includes "Substituted azoanthracene derivatives and intermediates for preparation thereof," which are crucial in modulating the human GLP-1 receptor for therapeutic purposes. Another notable patent is for "Phenylglyoxylic acid derivatives," which serve as essential intermediates in the synthesis of drug compounds.

Career Highlights:

Having worked at renowned companies like Transtech Pharma, Inc. and VTV Therapeutics LLC, Bondlela has honed his skills and expertise in the pharmaceutical industry. His innovative approach to drug development has led to the creation of groundbreaking technologies that have the potential to revolutionize the field.

Collaborations:

Throughout his career, Bondlela has collaborated with esteemed professionals in the industry, including Robert Carl Andrews and Adnan M. M. Mjalli. These collaborations have not only fueled creativity and innovation but have also resulted in the successful development of novel pharmaceutical products.

Conclusion:

In conclusion, Muralidhar Bondlela stands out as a pioneering inventor in the realm of pharmaceuticals. His passion for innovation and dedication to advancing healthcare through groundbreaking discoveries highlight his invaluable contributions to the field. Bondlela's patents and collaborations underscore his commitment to pushing the boundaries of pharmaceutical research, paving the way for a healthier future.

This text is generated by artificial intelligence and may not be accurate.